Skip to Main Content

Innovation to Impact: Dr. Lieping Chen and NextCure

September 16, 2016

Dr. Lieping Chen, the United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology) and Co-Director of the Cancer Immunology Program at Yale Cancer Center, is a pioneer in the field of immuno-oncology and his discoveries have led to life-saving drugs for cancer patients. Now, with the support of the Yale Office of Cooperative Research, Dr. Chen has launched a startup—NextCure—that is poised to lead to even more breakthrough treatments.

Submitted by John Curtis on September 07, 2016